Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome

Annals of Neurology

Volumn 79, Issue 4, 2016, Pages 560-568

  Park, Jong Moo ^a   Kang, Kyusik ^a   Cho, Yong Jin ^b   Hong, Keun Sik ^b   Lee, Kyung Bok ^c   Park, Tai Hwan ^d   Lee, Soo Joo ^a   Ko, Youngchai ^a   Han, Moon Ku ^e   Lee, Jun ^f   Cha, Jae Kwan ^g   Kim, Dae Hyun ^g   Kim, Dong Eog ^h   Kim, Joon Tae ⁱ   Choi, Jay Chol ^j   Yu, Kyung Ho ^k   Lee, Byung Chul ^k   Lee, Ji Sung ^l   Lee, Juneyoung ^m   Gorelick, Philip B ⁿ   Bae, Hee Joon ^e   more..

^a Eulji University   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Soonchunhyang University College of Medicine   (South Korea)

^d Seoul Medical Center   (South Korea)

^e Seoul National University Bundang Hospital   (South Korea)

^f Young Nam University Hospital   (South Korea)

^g Dong A University College of Medicine   (South Korea)

^h Dongguk University Ilsan Hospital   (South Korea)

ⁱ Chonnam National University Medical School   (South Korea)

^j Jeju National University College of Medicine   (South Korea)

^k Hallym University College of Medicine   (South Korea)

^l Asan Medical Center   (South Korea)

^m Korea University College of Medicine   (South Korea)

ⁿ MICHIGAN STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; LARGE ARTERY ATHEROSCLEROSIS; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; SMALL VESSEL OCCLUSION; CHEMICALLY INDUCED; COMPARATIVE STUDY; INTRACRANIAL HEMORRHAGES; MIDDLE AGED; REGISTER; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASPIRIN; BRAIN ISCHEMIA; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PLATELET AGGREGATION INHIBITORS; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84975698143     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24602     Document Type: Article

References (40)

1. Kernan WN, Ovbiagele B, Black HR, et al., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 2160-2236.
2. Goldstein LB, Bushnell CD, Adams RJ, et al., Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 517-584.
3. Antithrombotic Trialists C, Baigent C, Blackwell L, et al., Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009; 373: 1849-1860.
4. Sanossian N, Saver JL, Rajajee V, et al., Premorbid antiplatelet use and ischemic stroke outcomes. Neurology 2006; 66 (3): 319-323.
5. Ovbiagele B, Buck BH, Liebeskind DS, et al., Prior antiplatelet use and infarct volume in ischemic stroke. J Neurol Sci 2008; 264: 140-144.
6. O'Donnell M, Oczkowski W, Fang J, et al., Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol. 2006; 5: 749-754.
7. Paciaroni M, Agnelli G, Caso V, et al., Prior use of antithrombotic agents and neurological functional outcome at discharge in patients with ischemic stroke. J Thromb Haemost 2006; 4: 1957-1961.
8. Rist PM, Buring JE, Kase CS, et al., Effect of low-dose aspirin on functional outcome from cerebral vascular events in women. Stroke 2013; 44: 432-436.
9. Ricci S, Lewis S, Sandercock P, et al., Previous use of aspirin and baseline stroke severity: an analysis of 17 850 patients in the International Stroke Trial. Stroke 2006; 37: 1737-1740.
10. Kwok CS, Skinner J, Metcalf AK, et al., Prior antiplatelet or anticoagulant therapy and mortality in stroke. Heart 2012; 98: 712-717.
11. Kim WJ, Ko Y, Yang MH, et al., Differential effect of previous antiplatelet use on stroke severity according to stroke mechanism. Stroke 2010; 41: 1200-1204.
12. Bufalino VJ, Masoudi FA, Stranne SK, et al., The American Heart Association's recommendations for expanding the applications of existing and future clinical registries: a policy statement from the American Heart Association. Circulation 2011; 123: 2167-2179.
13. Kim BJ, Han MK, Park TH, et al., Current status of acute stroke management in Korea: a report on a multicenter, comprehensive acute stroke registry. Int J Stroke 2013; 9: 514-518.
14. Kim BJ, Park JM, Kang K, et al., Case characteristics, hyperacute treatment, and outcome information from the Clinical Research Center for Stroke-fifth division registry in South Korea. J Stroke 2015; 17: 1-16.
15. Adams H, Jr, Bendixen B, Kappelle L, et al., Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
16. Ko Y, Lee S, Chung JW, et al., MRI-based algorithm for acute ischemic stroke subtype classification. J Stroke 2014; 16: 161-172.
17. Rosenbaum PR, Rubin DB,. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41-55.
18. Robins JM, Hernan MA, Brumback B,. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11: 550-560.
19. Brookhart MA, Wyss R, Layton JB, et al., Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes 2013; 6: 604-611.
20. Hernan MA, Brumback B, Robins JM,. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11: 561-570.
21. Scott SC, Goldberg MS, Mayo NE,. Statistical assessment of ordinal outcomes in comparative studies. J Clin Epidemiol 1997; 50: 45-55.
22. Shuaib A, Lees KR, Lyden P, et al., NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007; 357: 562-571.
23. Joseph R, Han E, Tsering C, et al., Platelet activity and stroke severity. J Neurol Sci 1992; 108: 1-6.
24. Hallenbeck JM, Furlow TW,. Prostaglandin I2 and indomethacin prevent impairment of post-ischemic brain reperfusion in the dog. Stroke 1979; 10: 629-637.
25. Rosenblum WI, El-Sabban F,. Platelet aggregation in the cerebral microcirculation: effect of aspirin and other agents. Circ Res 1977; 40: 320-328.
26. Joseph R, D'Andrea G, Oster SB, et al., Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents. Stroke 1989; 20: 38-44.
27. Riepe MW, Kasischke K, Raupach A,. Acetylsalicylic acid increases tolerance against hypoxic and chemical hypoxia. Stroke 1997; 28: 2006-2011.
28. Grilli M, Pizzi M, Memo M, et al., Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 1996; 274: 1383-1385.
29. Kuhn W, Muller T, Bttner T, et al., Aspirin as a free radical scavenger: consequences for therapy of cerebrovascular ischemia. Stroke 1995; 26: 1959-1960.
30. Jauch EC, Saver JL, Adams HP, et al., Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
31. Panel, Mohr JP, Albers GW, et al., Etiology of stroke. Stroke 1997; 28: 1501-1506.
32. Grotta JC, Lemak NA, Gary H, et al., Does platelet antiaggregant therapy lessen the severity of stroke? Neurology 1985; 35: 632-636.
33. The SPS3 Investigators. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012; 367: 817-825.
34. Hart RG, Pearce LA, Aguilar MI,. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
35. January CT, Wann LS, Alpert JS, et al., 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2014; 130: e199-e267.
36. Diedler J, Ahmed N, Sykora M, et al., Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke 2010; 41: 288-294.
37. Austin PC, Mamdani MM,. A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use. Stat Med 2006; 25: 2084-2106.
38. Katz MH,. Multivariable Analysis: A Practical Guide for Clinicians, 2nd ed. Cambridge, UK: Cambridge University Press; 2006.
39. Lees KR, Bath PMW, Schellinger PD, et al., Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke 2012; 43: 1163-1170.
40. Ovbiagele B, Saver JL,. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level. Cerebrovasc Dis 2010; 29: 50-56.